Tissue Imaging Market Valued at USD 10.3 BILLION IN 2023, Growing at an 9.50% CAGR - Exclusive Report by MarkNtel Adviso

Comments · 97 Views

The Global Tissue Imaging Market size was valued at USD 10.3 billion in 2023 and is projected to reach USD 14.3 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 9.50% during the forecast period, i.e., 2024-30.

Market Insights and Analysis: Tissue Imaging Market Overview and Projections (2024-2030)

The Global Tissue Imaging Market size was valued at USD 10.3 billion in 2023 and is projected to reach USD 14.3 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 9.50% during the forecast period, i.e., 2024-30.

Top leading companies in the Tissue Imaging Market includes:

Abbott Laboratories, Roche Holding AG, Bio-Rad Laboratories, Bio SB, Inc., Agilent Technologies, Olympus Corporation, Abcam Plc, Biocare Medical LLC, Sakura Finetek., LifeSpan BioSciences, Inc., Hamamatsu Photonics K.K., Danaher Corporation, Merck KGaA., Thermo Fisher Scientific Inc., Becton, and Dickinson

Recent Developments

  • 2024: Roche Holding AG received the US FDA clearance for its whole-slide imaging system, the Roche Digital Pathology Dx, for use as an aid in clinical diagnosis. This system would help pathologists review and interpret digital images of scanned pathology slides.
  • 2024: Bio-Rad launched ChemiDoc Go Imaging System for highly sensitive benchtop gel and Western blot imaging.

Access the detailed PDF Sample report- https://www.marknteladvisors.com/query/request-sample/global-tissue-imaging-market.html              

Report Segmentation:

The market is categorized into the following segments in the report:

By Technology

-Mass Spectroscopy

--MALDI Imaging

--DESI Imaging

--SIMS Imaging

-Immunohistochemistry (IHC)

-Flow Cytometry

-Digital Pathology

-In Situ Hybridization (ISH)

--Fluorescence In-Situ Hybridization (FISH)

---DNA Fluorescence In-Situ Hybridization

---RNA Fluorescence In-Situ Hybridization

---Protein Fluorescence In-Situ Hybridization

--Chromogenic In-Situ Hybridization (CISH)

-Immunofluorescence

--Indirect Immunofluorescence (Secondary)

--Direct Immunofluorescence (Primary)

-Others (Confocal Microscopy, Electron Microscopy, etc.)

  • The Flow Cytometry segment had a considerable market share in the Global Tissue Imaging Market in 2023.

By Component

-Platforms

--Mass Spectroscopy Imaging (MSI) Platforms

--Flow Cytometry Analyzers

--Digital Pathology Scanners

--Immunohistochemistry Detection Systems

--In-Situ Hybridization Platforms

--Immunofluorescence Imaging Analysis Systems

--Tissue Microarray Platforms

--Others (Quantitative PCR Systems, Microscopy Accessories, etc.)

-Microscopes

--Optical Microscopes

---Compound Microscopes

---Digital Microscopes

---Fluorescence Microscopes

---Others (Polarizing Microscopes, Phase Contrast Microscopes, etc.)

-Electron Microscopes

---Scanning Electron Microscopes (SEM)

---Transmission Electron Microscopes (TEM)

--Scanning Probe Microscopes

--Others (Field Emission Scanning Electron Microscopes (FESEM), Low-Voltage Scanning Electron Microscopes (LVSEM), etc.)

-Consumables

--Antibodies Reagents

--Kits

--Probes

--Others (Buffers and Salts, Substrates, etc.)

-Software

-Accessories

By Therapeutic Application

-By Disease Research

--Oncology Research

--Infectious Diseases Research

--Neurological Disease Research

--Cardiovascular Disease Research

--Immunological Disease Research

--Others (Genetic Disease Research, Metabolic Disease Research, etc.)

-By Diagnostics

--Oncology Diagnostics

--Infectious Diseases Diagnostics

--Neurological Disease Diagnostics

--Cardiovascular Disease Diagnostics

--Others (Genetic Disease Diagnostics, Metabolic Disease Diagnostics, etc.)

By End User

-Hospitals and Diagnostic Laboratories

-Pharmaceutical Biotechnology Companies

-Contract Research Organizations (CROs)

-Others (Academic and Research Institutions, Specialty Clinics, etc.)

Explore Our Comprehensive Study Reports -  https://www.marknteladvisors.com/research-library/global-tissue-imaging-market.html           

Tissue Imaging Market Geographic Reach:

The Geographic Reach of the Tissue Imaging Market evaluates the spread and significance of Tissue Imaging market consumption across different regions/country, emphasizing areas with the largest market size and the most promising growth potential.

  • North America: The US, Canada, Mexico
  • Europe: Germany, Germany, The UK, France, Italy, Spain, Rest of Europe
  • Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia Pacific
  • South America: Brazil, Argentina, Rest of South America
  • Middle East Africa: UAE, Saudi Arabia, South Africa, Rest of the Middle East Africa

Note: If you require specific information not covered in the current report, we can provide it through customized option

Related Reports: -

https://www.openpr.com/news/3330443/global-energy-storage-market-exceeds-usd-435-4-billion-by-2030   

https://www.openpr.com/news/3330439/global-egg-powder-market-reaches-usd-3-92-billion-by-2030   

https://www.openpr.com/news/3330435/global-luxury-furniture-market-exceeds-usd-27-65-billion   

https://www.openpr.com/news/3330433/global-digital-pathology-market-reaches-usd-2-1-billion-in-2023   

https://www.openpr.com/news/3306575/data-governance-market-share-growth-size-revenue-trends   

Why choose Us?

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative quantitative research company, strive to deliver data to a substantial varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Comments